Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 50 Women only

Foley catheter plus oxytocin versus oxytocin alone for inducing labor after preterm PROM

Official title: Combination Oxytocin/Foley Versus Oxytocin Alone for Induction of Labor in Patients With Preterm Prelabor Rupture of Membranes

Run by Eastern Virginia Medical School · NCT07119398 · Data updated 2026-11-12

This trial tests whether adding a Foley catheter to oxytocin helps people with preterm PROM (34w0d–36w6d) go into labor and deliver faster than oxytocin alone.

More Preterm PROM (Pregnancy) trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment80 (estimated)
SponsorEastern Virginia Medical School
Academic / other
Locations1 site (Norfolk, Virginia)
StatusRecruiting
StartedJuly 14, 2025
Main results expectedJuly 30, 2026
Study endsDecember 30, 2026
Registry record updatedAugust 13, 2025
Trial IDNCT07119398 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 18–50 with PPROM between 34w0d and 36w6d, cervical dilation ≤2 cm, a cephalic fetus, and who can consent and receive care at the study site are ideal candidates.

Probably not a fit

Patients already in active labor, with cervical dilation >2 cm, chorioamnionitis, contraindications to a Foley, HIV, known fetal anomalies, or other exclusion criteria are unlikely to be eligible or benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with preterm prelabor rupture of membranes between 34 0/7 and 36 6/7 weeks, with a cervix ≤2 cm and a fetus in cephalic presentation, are enrolled at a single center. Enrolled participants receive either a Foley catheter plus oxytocin or oxytocin alone for induction and are monitored for labor progress, time to delivery, and maternal and neonatal outcomes. The trial excludes patients in spontaneous labor, with chorioamnionitis, significant cervical dilation, contraindications to a Foley, HIV, or known fetal anomalies. Study procedures and outcomes focus on whether the Foley plus oxytocin approach shortens the time to delivery and affects infection or other complications.

Why it matters

Potential benefit: If successful, adding a Foley catheter could shorten the time from induction to delivery and reduce the risks associated with prolonged membrane rupture.

How similar studies have gone: Previous randomized data show Foley plus oxytocin shortens time to delivery in term pregnancies and oxytocin versus misoprostol showed no clear difference in PPROM, but Foley use has not been prospectively tested in patients with PPROM.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients 18-50 years of age;
* The patient is fluent in English, physically and mentally able to understand the informed consent, and is willing to participate in this study;
* PPROM;
* Cervical dilation \</= 2cm
* Fetal cephalic presentation;
* The patient is between 34 weeks 0 days and 36 weeks 6 days of gestation at the time of enrollment. Gestational age will be determined by last menstrual period, confirmed with a first trimester ultrasound, per the recommended guidelines by the American College of Obstetricians and Gynecologists.

Exclusion Criteria:

* Spontaneous labor
* Known allergy to latex;
* Cervical dilation \>2cm;
* Chorioamnionitis;
* Contraindications to induction of labor or use of Foley for cervical ripening
* HIV
* Known or suspected fetal anomaly or aneuploidy;
* Prisoners.

Where it's running

  • Sentara Norfolk General Hospital
    Norfolk, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Marwan Ma'ayeh, MD — Eastern Virginia Medical School
  • Study coordinator: Kristin Ayers, MPH
  • Email: ayerskl@evms.edu
  • Phone: 7574460529

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.